Ksenia V. Kastanenka

发表

Optical Probes for In Vivo Brain Imaging

B. Bacskai, E. Galea, E. Hudry, 2015 .

A roadmap to integrate astrocytes into Systems Neuroscience

Kira E. Poskanzer, G. Perea, Rubén Moreno-Bote, 2019, Glia.

In Vivo Imaging in Neurodegenerative Diseases

B. Bacskai, Ksenia V. Kastanenka, Michal Arbel-Ornath, 2014 .

in Spinal Neurons of the Chick Embryo Post-Episode Depression of GABAergic Transmission

Michael J. O'Donovan, P. Wenner, L. Landmesser, 2015 .

Hyperactive somatostatin interneurons near amyloid plaque and cell-type-specific firing deficits in a mouse model of Alzheimer’s disease

B. Bacskai, Steven S. Hou, Alyssa N. Russ, 2022, bioRxiv.

Diaphragm Neuromuscular Junctions Synaptic Vesicle Distribution and Release at Rat

L. Landmesser, Chao Zhang, K. Shokat, 2015 .

Trafficking in NCAM Knockout Mice Adrenal Chromaffin Cells Exhibit Impaired Granule

L. Landmesser, Ksenia V. Kastanenka, L. Polo-Parada, 2015 .

Novel Botanical Therapeutic NB-02 Effectively Treats Alzheimer’s Neuropathophysiology in an APP/PS1 Mouse Model

B. Bacskai, Ksenia V. Kastanenka, Sang-Zin Choi, 2020, eNeuro.

Novel botanical therapeutic NB-02 effectively treats Alzheimer’s neuropathophysiology in 1 an animal model APP/PS1 mouse model 2

B. Bacskai, Ksenia V. Kastanenka, Sang-Zin Choi, 2020 .

Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice

P. Weinreb, B. Bacskai, T. Bussiere, 2016, The Journal of Neuroscience.

Building transformers from neurons and astrocytes

D. Krotov, L. Kozachkov, Ksenia V. Kastanenka, 2022, bioRxiv.

Low frequency visual stimulation enhances slow wave activity without disrupting the sleep pattern in mice

B. Bacskai, Ksenia V. Kastanenka, D. Gerashchenko, 2022, Scientific Reports.

Reactive astrocyte nomenclature, definitions, and future directions

Kira E. Poskanzer, B. Khakh, C. Rose, 2021, Nature Neuroscience.

Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of Alzheimer’s disease

B. Bacskai, Steven S. Hou, Ksenia V. Kastanenka, 2022, Communications Biology.

In Vivo Activation of Channelrhodopsin-2 Reveals That Normal Patterns of Spontaneous Activity Are Required for Motoneuron Guidance and Maintenance of Guidance Molecules

L. Landmesser, Ksenia V. Kastanenka, 2010, The Journal of Neuroscience.

An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging

B. Bacskai, G. Krafft, Ksenia V. Kastanenka, 2018, Scientific Reports.

Pathogenic PS1 phosphorylation at Ser367

B. Hyman, B. Bacskai, O. Berezovska, 2017, eLife.

Slow Wave Sleep Is a Promising Intervention Target for Alzheimer’s Disease

I. Timofeev, B. Bacskai, Ksenia V. Kastanenka, 2020, Frontiers in Neuroscience.

Frequency-dependent exacerbation of Alzheimer’s disease neuropathophysiology

B. Bacskai, S. Gomperts, Steven S. Hou, 2019, Scientific Reports.

Optogenetic Restoration of Disrupted Slow Oscillations Halts Amyloid Deposition and Restores Calcium Homeostasis in an Animal Model of Alzheimer’s Disease

B. Bacskai, Steven S. Hou, Ksenia V. Kastanenka, 2017, PloS one.

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease

J. Keith Joung, Bradley T. Hyman, Lars Lannfelt, 2018, Molecular therapy. Nucleic acids.

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

Claire Paquet, Sylvain Lehmann, Florence Pasquier, 2015, Alzheimer's Research & Therapy.

Calcium sensor Yellow Cameleon 3.6 as a tool to support the calcium hypothesis of Alzheimer's disease

Ksenia V. Kastanenka, Morgan R. Miller, Yee Fun Lee, 2023, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Novel botanical drug DA-9803 prevents deficits in Alzheimer’s mouse models

B. Bacskai, Ksenia V. Kastanenka, Song-hyen Choi, 2018, Alzheimer's Research & Therapy.

Optogenetic Targeting of Astrocytes Restores Slow Brain Rhythm Function and Slows Alzheimer’s Disease Pathology

A. Araque, B. Bacskai, S. Gomperts, 2023, Research square.

An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging

B. Bacskai, G. Krafft, Ksenia V. Kastanenka, 2018, Scientific Reports.

Novel botanical drug DA-9803 prevents deficits in Alzheimer’s mouse models

B. Bacskai, Ksenia V. Kastanenka, Song-hyen Choi, 2018, Alzheimer's Research & Therapy.

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

F. Pasquier, S. Lehmann, J. Touchon, 2015, Alzheimer's Research & Therapy.

Frequency-Dependent Modes of Synaptic Vesicle Endocytosis and Exocytosis at Adult Mouse Neuromuscular Junctions

L. Landmesser, Ksenia V. Kastanenka, L. Polo-Parada, 2011, The Journal of Neuroscience.

Optogenetic targeting of astrocytes restores slow brain rhythm function and slows Alzheimer’s disease pathology

B. Bacskai, S. Gomperts, E. Galea, 2023, Scientific reports.

Frequency-dependent exacerbation of Alzheimer’s disease neuropathophysiology

B. Bacskai, S. Gomperts, Steven S. Hou, 2019, Scientific Reports.

Optogenetic-mediated increases in in vivo spontaneous activity disrupt pool-specific but not dorsal-ventral motoneuron pathfinding

L. Landmesser, Ksenia V. Kastanenka, 2013, Proceedings of the National Academy of Sciences.

Slow wave activity disruptions and memory impairments in a mouse model of aging

Ksenia V. Kastanenka, M. J. Abedin, Moustafa Algamal, 2024, Neurobiology of Aging.

Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer’s disease model

E. Lo, B. Bacskai, S. Gomperts, 2023, Molecular Neurodegeneration.